Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Clinical trial NCT02614495 · COMPLETED

Trial details

NCT number: NCT02614495
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid Carcinoma

Start date: 2016-02-24
Primary completion: 2018-09-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.